Olema Oncology at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
Olema Oncology at SABCS 2026 in San Antonio: Booth 1342.
| Organization | SABCS 2026 Attendance |
|---|---|
Olema Oncology San Francisco, CA | |
Clinical-stage company developing palazestrant, an oral estrogen receptor antagonist and degrader, in Phase 3 trials for ER+/HER2- advanced breast cancer. | Booth Exhibiting at Booth 1342 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Find decision makers at Olema Oncology
Tell us what you sell and we’ll find the people at Olema Oncology most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction